Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.
An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.
Launch your career as an editor or validate your experience with a respected credential. Following Editors Canada Professional Editorial Standards, our online certificate program covers the four ...